Skip to main content
. Author manuscript; available in PMC: 2023 Apr 4.
Published in final edited form as: Semin Thromb Hemost. 2019 Jun 14;46(5):524–544. doi: 10.1055/s-0039-1692395

Fig. 2.

Fig. 2

Schematic representations of various design approaches involving direct modification of therapeutic molecules in the development of vascular nanomedicine. PEG, polyethylene glycol; Alb, albumin.